Thames Valley Cancer Network

Update in Leukaemia & Haematology TSSG Meeting

at:   Oxford Belfry Hotel

on:   Monday 24th January 2011

TO SEE THE AVAILABLE PRESENTATIONS, CLICK ON THE RELEVANT TALK

PROGRAMME

  9.10 - 9.45: Registration and tea/coffee

Session 1. Chairman: Prof Jim Wainscoat (ORH, Oxford)
 
  9.45 - 10.15: The role of transplantation in CML in the era of TKI therapy
Dr Andy Peniket (ORH, Oxford)

10.15 - 10.45: Management of myelofibrosis new agents and role of transplantation
Dr Adam Mead (ORH, Oxford)

10.45: Coffee

Session 2. Chairman: Dr Tim Littlewood (ORH, Oxford)
 
11.15 - 12.00: AML trials in the UK. Current status and future prospects
Dr Richard Hills ((University Hospital of Wales, Cardiff)

12.00 - 12.30: Case studies in AML
Dr Peter Mackie (Heatherwood and Wexham Park Hospitals)

12.30 - 13.00: Overview of advances in AML
Dr Paresh Vyas (ORH, Oxford)

13.00:Lunch

14.00:Haematology TSSG meeting
 
Approval has been granted by the Royal College of Pathologists for a maximum of 3 CPD points.
 
Please feel free to contact Bridget Watson for further information.

We would like to thank the companies listed below for their sponsorship of this meeting:

 
   
     
 
Click on the logo above for a link to the company's web site.


Return to Home page